<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100609004141N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-18</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Assessing effect of flow rate of CO2 gas on postoperative complications in laparoscopic surgery</public_title>
      <acronym></acronym>
      <scientific_title>Assessing effect of flow rate of CO2 gas on postoperative complications in laparoscopic surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-09-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>104</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/36011</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The assignment of patients to each group will be applied based on randomization block to control the effect of age and sex. And so on the proportion of sex (women and men) and age (under 40, 40 years old and more) will be approximately the same in the two groups, Blinding description: In this study, the patients and the peoples how measuring the variables would be unaware of the presence of patients in the first group and or in the second groups. Only the surgeon aware about grouping, after of ending the evoluation of necessary variables, groups of each person will be spesified in cheklist, based on coding system.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Flow rate of CO2 gas , Postoperative complications in cholecystectomy laparoscopic surgery. Condition 2: Flow rate of CO2 gas , Postoperative complications in herniorafi laparoscopic surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention: In order to be able to do surgery in the abdomen, in new surgery, they injected some CO2 into the abdominal area, until with the opening of the organs from one another, access is easy for surgeon. Before inserting a laparoscope into the abdomen through the primary port, the peritoneal cavity is fills up with CO2 by an inoculatory device (a device that sends the calculated amount of gas from the gas through a controlled pressure between 18-12 mm Hg into the abdomen). In many cases, determining the flow rate of CO2 gas that can have different effect on organs, done by the surgeon. Speed of entering the gas into the abdominal cavity at the beginning of the laparoscopic surgery is done in both low speed and high speed in according to (L / min CO2). Intervention group: Patients who are eligible for inclusion in the study are included in the study and without knowing that it is only the first group (under the operation with blowing CO2 gas at low speed) or the second group (under the operation with blowing CO2 gas at high speed) , surgery happens to them. In this section, the intervention group 1; people are in the first group. Intervention 2: Intervention: In order to be able to do surgery in the abdomen, in new surgery, they injected some CO2 into the abdominal area, until with the opening of the organs from one another, access is easy for surgeon. Before inserting a laparoscope into the abdomen through the primary port, the peritoneal cavity is fills up with CO2 by an inoculatory device (a device that sends the calculated amount of gas from the gas through a controlled pressure between 18-12 mm Hg into the abdomen). In many cases, determining the flow rate of CO2 gas that can have different effect on organs, done by the surgeon. Speed of entering the gas into the abdominal cavity at the beginning of the laparoscopic surgery is done in both low speed and high speed in according to (L / min CO2). Intervention group: Patients who are eligible for inclusion in the study are included in the study and without knowing that it is only the first group (under the operation with blowing CO2 gas at low speed) or the second group (under the operation with blowing CO2 gas at high speed) , surgery happens to them. In this section, the intervention group 2; people are in the second group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After the samples being unidentifiable, data is publishable .

When:
The access period; 
Starts 6 months after publishing the results

To whom:
Researchers working in academic and scientific institutions

Conditions:
People who try to help science can use data.

Where to obtain:
Expert of Research Unit of Imam Khomeini Hospital in Kermanshah , Sharman Rahmani , sh.rahmani90@yahoo.com

How to obtain:
1- Send a request to sh.rahmani90@yahoo.com 
2. The purpose of the data request, stated clearly. 
3- If confirmed by the main executor, immediately proceed.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Behnam Reza Makhsosy</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini hospital in Kermanshah, Naghliye avenue , Kermanshah</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6718743161</zip>
        <telephone>+98 83 3728 5054</telephone>
        <email>dr.makhsosy@kums.ac.ir</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kermanshah University of Medical Sciences</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Khomeini hospital in Kermanshah, Naghliye avenue , Kermanshah</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6718743161</zip>
        <telephone>+98 83 3728 5054</telephone>
        <email>dr.makhsosy@kums.ac.ir</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Ages between 18 and 65 years old
Have laparoscopic surgery</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with history of motion sickness, diabetes, cardiovascular failure
Patients with concurrent surgery
Patients under treatment with narcotic drugs or non-steroidal anti-inflammatory drugs
History of severe nausea and vomiting in past surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K81.0</hc_code>
      <hc_code>K43</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute cholecystitis</hc_keyword>
      <hc_keyword>Ventral hernia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention: In order to be able to do surgery in the abdomen, in new surgery, they injected some CO2 into the abdominal area, until with the opening of the organs from one another, access is easy for surgeon. Before inserting a laparoscope into the abdomen through the primary port, the peritoneal cavity is fills up with CO2 by an inoculatory device (a device that sends the calculated amount of gas from the gas through a controlled pressure between 18-12 mm Hg into the abdomen). In many cases, determining the flow rate of CO2 gas that can have different effect on organs, done by the surgeon. Speed of entering the gas into the abdominal cavity at the beginning of the laparoscopic surgery is done in both low speed and high speed in according to (L / min CO2). Intervention group: Patients who are eligible for inclusion in the study are included in the study and without knowing that it is only the first group (under the operation with blowing CO2 gas at low speed) or the second group (under the operation with blowing CO2 gas at high speed) , surgery happens to them. In this section, the intervention group 1; people are in the first group.</i_keyword>
      <i_keyword>Intervention: In order to be able to do surgery in the abdomen, in new surgery, they injected some CO2 into the abdominal area, until with the opening of the organs from one another, access is easy for surgeon. Before inserting a laparoscope into the abdomen through the primary port, the peritoneal cavity is fills up with CO2 by an inoculatory device (a device that sends the calculated amount of gas from the gas through a controlled pressure between 18-12 mm Hg into the abdomen). In many cases, determining the flow rate of CO2 gas that can have different effect on organs, done by the surgeon. Speed of entering the gas into the abdominal cavity at the beginning of the laparoscopic surgery is done in both low speed and high speed in according to (L / min CO2). Intervention group: Patients who are eligible for inclusion in the study are included in the study and without knowing that it is only the first group (under the operation with blowing CO2 gas at low speed) or the second group (under the operation with blowing CO2 gas at high speed) , surgery happens to them. In this section, the intervention group 2; people are in the second group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The amount of pain after laparoscopic surgery. Timepoint: 1- Immediately after the start of surgery                                                          2-  Three months after surgery. Method of measurement: Visual Measurement Scale; VAS.</prim_outcome>
      <prim_outcome>The amount of nausea after laparoscopic surgery. Timepoint: 1- Immediately after the start of surgery                                                          2-  Three months after surgery. Method of measurement: Visual Measurement Scale; VAS.</prim_outcome>
      <prim_outcome>The amount of vomit after laparoscopic surgery. Timepoint: 1- Immediately after the start of surgery                                                          2-  Three months after surgery. Method of measurement: Visual Measurement Scale; VAS.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-06-12</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Deputy of Research and Technology, Building No. 2, Shahid Beheshti Blvd., Kermanshah Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
